H|T: The Healthtech Times – Canadian healthtech stocks struggle to please shareholders
Plus: Peloton’s earnings are even worse than expected.
Healthtech
Well Health Technologies posts record Q1 revenue, announces $30 million bought deal offering to fuel acquisitions
Despite record revenues the last two quarters, Well’s share price has fallen nearly 43 percent over six months.
Dialogue, LifeSpeak struggle to please shareholders with first quarter 2022 results
Both healthtech companies noted user-driven revenue growth while share prices continue to tumble.
H|T: The Healthtech Times – Zymeworks has the blues
Plus: Think Research to continue acquisition spree with new $25 million credit facility.
Think Research posts record 438 percent revenue increase in Q4 2021 following acquisitions
Think Research saw 178 percent YoY rise in revenue, nearly tripled net loss last year.
Cyno secures $2.3 million seed round to bolster virtual care for employees
Cyno users can choose between individual or group health services.
Nicoya acquires University of Toronto spinout LSK Technologies to bolster testing capabilities, expedite product roadmap
Deal adds LSK’s “lab-in-a-box” testing platform to Nicoya’s portfolio of digital proteomics tech.
H|T: The Healthtech Times – Robots combat nurse burnout
Plus: Clipboard Health, which matches health workers with facilities, raises $80M.
Think Research to continue acquisition spree with new $25 million credit facility
Think Research has been actively purchasing companies since its TSXV debut.
Former Shopify CTO Jean-Michel Lemieux joins BenchSci advisory board
BenchSci is on a mission to re-imagine biomedical research through AI.
H|T: The Healthtech Times – Dialogue leads to deals
Plus: Peloton’s plan to staunch bleeding: Slash Bike prices, raise subscription cost.
Vetster raises $30 million in Series B, partners with investor Pet Meds
Vetster puts its paws on a new partnership.
H|T: The Healthtech Times – Oura breaks billion dollar ring
Plus: CloudMD, Think Research announce changes to executive suites.
Dialogue to acquire UK-based Tictrac for up to $56 million
Dialogue’s largest acquisition continues company’s pre-and-post-IPO spree.
University of Alberta spinout DrugBank closes $9 million from Brightspark, Amplitude, Theodorus to fuel drug discovery with its data platform
DrugBank wants to ‘be the shovel’ in a gold rush of new medical innovation.